webinar register page

Webinar banner
EyeSeeYou Vision Health Panel | Biosimilars in Ophthalmology: Is there a big change on the horizon?
Biosimilars have been used as a cost-saving alternative treatment to biologics in rheumatology and other treatment areas. Recent biosimilar policies across Canada suggest the entry of biosimilars into the field of ophthalmology. While biosimilars may be an emerging treatment option in ophthalmology, stakeholders are raising concerns regarding the appropriate uses of biosimilars in ophthalmology.

Awareness of the emerging issue of biosimilars in ophthalmology is the first step in overcoming treatment concerns and uncertainties, facilitating the clinical consultation and ensuring biosimilar policies are patient-centered.

Aug 12, 2020 07:00 AM in Eastern Time (US and Canada)

* Required information
Loading